Meyka Pro banner
nDatalyze Corp.

nDatalyze Corp. Fundamental Analysis (CNQ: NDAT.CN)

NDAT.CNCNQ
HealthcareMedical - Healthcare Information Services
$0.07
$0.010(12.50%)
Canadian Market is Open · 10:11

nDatalyze Corp. Fundamental Analysis (CNQ: NDAT.CN)

nDatalyze Corp. (CNQ: NDAT.CN) shows weak financial fundamentals with a PE ratio of -16.67, profit margin of 0.00%, and ROE of -49.83%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position11.45%
PEG Ratio-0.15
Current Ratio18.85

Areas of Concern

ROE-49.83%
Operating Margin0.00%
We analyze NDAT.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -24.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-24.8/100

We analyze NDAT.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

NDAT.CN struggles to generate sufficient returns from assets.

ROA > 10%
-61.92%

Valuation Score

Excellent

NDAT.CN trades at attractive valuation levels.

PE < 25
-16.67
PEG Ratio < 2
-0.15

Growth Score

Weak

NDAT.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

NDAT.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
18.85

Profitability Score

Weak

NDAT.CN struggles to sustain strong margins.

ROE > 15%
-4982.72%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is NDAT.CN Expensive or Cheap?

P/E Ratio

NDAT.CN trades at -16.67 times earnings. This suggests potential undervaluation.

-16.67

PEG Ratio

When adjusting for growth, NDAT.CN's PEG of -0.15 indicates potential undervaluation.

-0.15

Price to Book

The market values nDatalyze Corp. at 8.92 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

8.92

EV/EBITDA

Enterprise value stands at -14.38 times EBITDA. This is generally considered low.

-14.38

How Well Does NDAT.CN Make Money?

Net Profit Margin

For every $100 in sales, nDatalyze Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-49.83 in profit for every $100 of shareholder equity.

-49.83%

ROA

nDatalyze Corp. generates $-61.92 in profit for every $100 in assets, demonstrating efficient asset deployment.

-61.92%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

NDAT.CN converts -3.14% of its market value into free cash.

-3.14%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-16.67

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.15

vs 25 benchmark

P/B Ratio

Price to book value ratio

8.92

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

18.85

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.50

vs 25 benchmark

ROA

Return on assets percentage

-0.62

vs 25 benchmark

ROCE

Return on capital employed

-0.71

vs 25 benchmark

How NDAT.CN Stacks Against Its Sector Peers

MetricNDAT.CN ValueSector AveragePerformance
P/E Ratio-16.6732.02 Better (Cheaper)
ROE-49.83%569.00% Weak
Net Margin0.00%29961.00% Weak
Debt/Equity0.000.53 Strong (Low Leverage)
Current Ratio18.855.67 Strong Liquidity
ROA-61.92%-96.00% (disorted) Weak

NDAT.CN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews nDatalyze Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ